Janus Henderson Group’s Orthofix Medical OFIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-19,147
Closed -$214K 2447
2025
Q2
$214K Hold
19,147
﹤0.01% 2298
2025
Q1
$307K Hold
19,147
﹤0.01% 2194
2024
Q4
$335K Hold
19,147
﹤0.01% 2207
2024
Q3
$299K Hold
19,147
﹤0.01% 2275
2024
Q2
$254K Sell
19,147
-183
-0.9% -$2.51K ﹤0.01% 2288
2024
Q1
$280K Buy
19,330
+4
+0% +$55 ﹤0.01% 2263
2023
Q4
$261K Sell
19,326
-28
-0.1% -$329 ﹤0.01% 2299
2023
Q3
$249K Buy
19,354
+3
+0% +$54 ﹤0.01% 2276
2023
Q2
$349K Sell
19,351
-20
-0.1% -$374 ﹤0.01% 2175
2023
Q1
$324K Buy
+19,371
New +$379K ﹤0.01% 2246

Other funds holding OFIX

Janus Henderson Group's OFIX Position: Q3 2025 in Review

Janus Henderson Group sold out of Orthofix Medical (OFIX) in Q3 2025, closing a stake of 19,147 shares — an estimated $214K sold.

Janus Henderson Group first reported a position in OFIX in Q1 2023 and held it in 10 quarters. The position peaked at $349K in Q2 2023. 145 funds tracked by Wall St. Rank hold OFIX as of Q3 2025.

  • Janus Henderson Group reported no remaining Orthofix Medical position as of Q3 2025 after selling out during the quarter.
  • Janus Henderson Group sold 19,147 Orthofix Medical shares in Q3 2025, an estimated $214K.
  • Janus Henderson Group first reported a position in Orthofix Medical in Q1 2023 and held it in 10 quarters.
  • Janus Henderson Group's Orthofix Medical position peaked at $349K in Q2 2023.
  • 145 funds tracked by Wall St. Rank held Orthofix Medical as of Q3 2025.

Based on Janus Henderson Group's 13F filing for Q3 2025, filed 14 Nov 2025.